157
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review

, , ORCID Icon &
Pages 181-197 | Received 02 Sep 2023, Accepted 16 Jan 2024, Published online: 10 Apr 2024